Tumor Response [clinicaltrials_resource:NCT00190983/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Tumor Response [clinicaltrials_resource:NCT00190983/outcome/1]
Bio2RDF identifier
NCT00190983/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00190983/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
All enrolled participants who experienced disease progression.
All enrolled participants who ...... =0) or partial response (n=4).
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
baseline to measured progressive disease (up to 5 years)
baseline until death from any cause (up to 5 years)
baseline until documented tumor progression (up to 5 years)
time of initial response until documented tumor progression (up to 5 years)
type [clinicaltrials_vocabulary:type]
alternate
Tumor Response
@en
identifier
clinicaltrials_resource:NCT00190983/outcome/1
title
Best response recorded from th ...... rogression") during treatment.
@en
type
label
Tumor Response [clinicaltrials_resource:NCT00190983/outcome/1]
@en